PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28338324-0	2017	Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101.	lorcaserin	101-111	5-hydroxytryptamine receptor 2C	Rattus norvegicus	66-72	
28338324-1	2017	Lorcaserin (LOR) is a selective 5-HT2C receptor agonist that has been FDA approved as a treatment for obesity.	lorcaserin	0-10	5-hydroxytryptamine receptor 2C	Rattus norvegicus	32-38	
28338324-1	2017	Lorcaserin (LOR) is a selective 5-HT2C receptor agonist that has been FDA approved as a treatment for obesity.	lorcaserin	12-15	5-hydroxytryptamine receptor 2C	Rattus norvegicus	32-38